- On sale!
Search here...
New 100 capsuls.
Buy 5-pack SAVE 10%
Products Information
This product provides a premium source of Omega3 essential fatty acids sourced from New Zealand fish oil. Cultures with traditionally high amounts of Omega3 in their diets are known to have a reduced incidence of heart disease.
Dosage
Take 1-3 capsules daily with benefit the cardiovascular system and overall health, or as professionally advised.
Ingredients
Cold water fish oil 1000mg providing EPA 180mg, DHA 120mg.
No artificial flavorings, preservatives, sugar, salt, corn, yeast, gluten lactose added.
Omega-3 fatty acids are a form of polyunsaturated fats, one of four basic types of fat that the body derives from food. (Cholesterol, saturated fat, and monounsaturated fat are the others.) All polyunsaturated fats, including the omega-3s, are increasingly recognized as important to human health. Polyunsaturated fatty acids, however, are actually good for you. Omega-3 fatty acids include eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA), both found primarily in oily cold-water fish such as tuna, salmon, and mackerel.
Scientists made one of the first associations between omega-3s and human health while studying the Inuit (Eskimo) people of Greenland in the 1970s. As a group, the Inuit suffered far less from certain diseases than their European counterparts. Yet their diet was very high in fat from eating whale, seal, and salmon. Eventually researchers realized that these foods were all rich in omega-3 fatty acids, which provided real disease-countering benefits.
There are no known drug or nutrient interactions associated with increased consumption of omega-3 fatty acids through foods. However, if you decide to take omega-3s through supplements (especially those containing fish oils), be sure to check with your doctor first if you are taking a blood-thinner such as warfarin or heparin.
One benefit of omega-3 fatty acids is that they are very safe to consume. However, most sources recommend that fish consumption be limited to two to three servings weekly because so many fish are tainted with mercury and other contaminants. Fish oil capsules don't present this same risk.
References:
Alexander J.W., Immunonutrition: the role of Omega-3 fatty acids, Nutrition. 1998 Jul-Aug; 14 (7-8): 627-33.
Andrioli G., Carletto A., Guarini P., Galvani S., Biasi D., Bellavite P., Corrocher R., Differential effects of dietary supplementation with fish oil or soy lecithin on human platelet adhesion, Thromb Haemost. 1999 Nov; 82 (5): 1522-7.
Brown E.R., Subbaiah P.V., Differential effects of eicosapentaenoic acid and docosahexaenoic acid on human skin fibroblasts, Lipids. 1994 Dec; 29 (12): 825-9.
Donadio J.V. Jr, Grande J.P., Bergstralh E.J., Dart R.A., Larson T.S., Spencer D.C., The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group, J Am Soc Nephrol. 1999 Aug; 10 (8): 1772-7.
Edwards R., Peet M., Shay J., Horrobin D., Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients, J Affect Disord. 1998 Mar; 48 (2-3): 149-55.
Hodge L., Salome C.M., Peat J.K., Haby M.M., Xuan W., Woolcock A.J., Consumption of oily fish and childhood asthma risk, Med J Aust. 1996 Feb 5; 164 (3): 137-40.
Horrocks L.A., Yeo Y.K., Health benefits of docosahexaenoic acid (DHA), Pharmacol Res. 1999 Sep; 40 (3): 211-25.
Kremer J.M., Lawrence D.A., Petrillo G.F., Litts L.L., Mullaly P.M., Rynes R.I., Stocker R.P. Parhami N., Greenstein N.S., Fuchs B.R., et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs. Clinical and immune correlates. Arthritis Rheum. 1995 Aug; 38 (8): 1107-14.
Malasanos T.H., Stacpoole P.W., Biological effects of omega-3 fatty acids in diabetes mellitus, Diabetes Care. 1991 Dec; 14 (12): 1160-79.
Naliwaiko K., Araujo R.L., da Fonseca R.V., Castilho J.C., Andreatini R., Bellissimo M.I., Oliveira B.H., Martins E.F., Curi R., Fernandes L.C., Ferraz A.C., Effects of fish oil on the central nervous system: a new potential antidepressant? Nutr Neurosci. 2004 Apr; 7 (2): 91-9.
Navarro E., Esteve M., Olive A., Klaassen J., Cabre E., Tena X., Fernandez-Banares F., Pastor C., Gassull M.A., Abnormal fatty acid pattern in rheumatoid arthritis. A rationale for treatment with marine and botanical lipids, J Rheumatol. 2000 Feb; 27 (2): 298-303.
Olsen S.F., Soorensen J.D., Secher N.J., Hedegaard M., Henriksen T.B., Hansen H.S., Grant A., Fish oil supplementation and duration of pregnancy. A randomized controlled trial, Ugeskr Laeger. 1994 Feb 28; 156 (9): 1302-7.
Peck L.W., Essential fatty acid deficiency in renal failure: can supplements really help? J Am Diet Assoc. 1997 Oct; 97 (10 Suppl 2): S150-3.
Roynette C.E., Calder P.C., Dupertuis Y.M., Pichard C., n-3 polyunsaturated fatty acids and colon cancer prevention, Clin Nutr. 2004 Apr; 23 (2): 139-51.
SanGiovanni J.P., Chew E.Y., The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina, Prog Retin Eye Res. 2005 Jan; 24 (1): 87-138.
Schectman G., Kaul S., Kissebah A.H., Effect of fish oil concentrate on lipoprotein composition in NIDDm, Diabetes. 1988 Nov; 37 (11): 1567-73.
Shahar E., Folsom A.R., Melnick S.L., Tockman M.S., Comstock G.W., Gennaro V., Higgins M.W., Sorlie P.D., Ko W.J., Szklo M., Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease, Atherosclerosis risk in communities study investigators, Engl J med. 1994 Jul 28; 331 (4): 228-33.
Simopoulos A.P., Omega-3 fatty acids in health and disease and in growth and development, Am J Clin Nutr. 1991 Sep; 54 (3): 438-63.
Toft I., Bonaa K.H., Ingebretsen O.C., Nordov A., Jenssen T., Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomised, controlled trial. Ann Intern Med. 1995 Dec 15; 123 (12): 911-8.
Von Schacky C., Angerer P., Kothny W., Theisen K., Mudra H., The effect of dietary Omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial, Ann Intern Med. 1999 Apr 6; 130 (7): 554-62.
OME1